Twitter Subscribe Download
Menu
openlabnotebooks.org

openlabnotebooks.org

A growing team of groundbreaking scientists around the world are now sharing their lab notebooks online

Primary Menu

Skip to content
  • Home
  • Laboratories
    • Active
      • Amy Ramsey (Univ. of Toronto)
      • BCCRC, Univ. of British Columbia
      • BioZone (Univ. of Toronto)
      • Catalyst UNC Chapel Hill
      • Cheryl Arrowsmith (Univ. of Toronto)
      • CMD Oxford
      • Diamond Light Source
      • Emory university
      • Michael Taylor (SickKids Hospital Toronto)
      • Montreal Neurological Institute
      • Nick Goldman (EBI)
      • Pietro Roversi (Univ. of Leicester)
      • Qhetem, USP, Brazil
      • Ray Truant (McMaster Univ.)
      • SGC UNC Chapel Hill
      • SGC Univ. of Oxford
      • SGC Univ. of Toronto
    • Past
      • Antoine Claessens
      • SGC Karolinska
  • People
    • Active
      • Alfredo Picado
      • Alma Seitova
      • Amy Ramsey
      • Angela Kwak
      • Anirban Ghoshal
      • Anwar Hossain
      • Arunima
      • Ashley Hutchinson
      • Ben Eduful
      • Benjamin Dai
      • Claudia Alvarez
      • Danton Ivanochko
      • David Dilworth
      • David Drewry
      • Edward Anderson
      • Elisa Gibson
      • Elizabeth Zoeller
      • Ellie Williams
      • Eve Carter
      • Evianne Rovers
      • Fang-Chi Chang
      • Hadley Sheppard
      • Jong Fu Wong
      • Jose Brandao-Neto
      • Joseph Newman
      • Katheron Intson
      • Lakshi Selvaratnam
      • Liz Brown
      • Louisa Temme
      • Madison Edwards
      • Magdalena Szewczyk
      • Mandeep Mann
      • Muthu Ramalingam Bose
      • Nergis Imprachim
      • Nicola De Maio
      • Oliver Arnolds
      • Opher Gileadi
      • Pegah Ghiabi
      • Peter Brown
      • Peter Stogios
      • Pietro Roversi
      • Rachel Harding
      • Sabrina Mackinnon
      • Sara Boosaliki
      • Serap Beldar
      • Setayesh Yazdani
      • Stephen R. Armstrong
      • Suzanne Ackloo
      • Tamara Maiuri
      • Tammy Havener
      • Taraneh Hajian
      • Thiago dos Santos
      • Thomas M. Durcan
      • Tobias Krojer
      • Victoria Vu
      • Yuanye Yan
      • Yufeng Pan
    • Past
      • Antoine Claessens
      • Carla Alamillo
      • Carmen Jimenez Antunez
      • Carolyn Marks
      • Genna Luciani
      • Grant Mills
      • Haresh Ajani
      • Jacob McAuley
      • Jolene Ho
      • Kaleb Naegeli
      • Megha Abbey
      • Nirav Kapadia
      • Roslin Adamson
      • Sean O’Byrne
      • Wen Yih Aw
  • Diseases
    • Active
      • Alzheimer’s disease
      • Amyotrophic Lateral Sclerosis (ALS)
      • Batten disease
      • Chordoma
      • COVID-19
      • Diffuse intrinsic pontine glioma
      • Ependymoma
      • Fibrodysplasia ossificans progressiva
      • GRIN disorder
      • Huntington’s disease
      • Influenza
      • iPSC Disease modelling
      • Leukemia
      • Malaria
      • Parkinson’s disease and neurodevelopmental disorders
      • Primary Hyperoxaluria
      • Rare disease
    • Past
      • Dravet syndrome
  • Projects
    • Active
      • ACVR1/ALK2
      • ALS-Reproducible Antibody Platform (ALS-RAP)
      • Cell assay reports
      • Chromatin factors
      • E3 ligases
      • Epigenetic targets in Medulloblastoma
      • EZHIP
      • GTPase-GEF complex
      • HAO1
      • HDACs
      • Helicases
      • HERO Glove
      • Huntingtin
      • Influenza computational genomics
      • Investigating Outdoor Mobility of Older Adults
      • iPSCs
      • Ligandable Genome
      • NMDA
      • Non-hormonal Contraception
      • NSD3
      • Open Secretion Rescue
      • PRC2
      • PRDM methyltransferases
      • PRMTs
      • Protein purification protocols
      • READDI-AC
      • SARS-CoV-2 computational genomics
      • SARS-CoV-2 NSP14
      • SETDB1
      • Spike
      • TBXT (brachyury) inhibitors
      • Toronto Open Access SARS-CoV-2 Protein Manufacturing Center
      • TREAT-AD
      • Understudied Kinases
      • USP5
      • USPs
      • WDR proteins
      • WDR41
      • XChem
    • Past
      • EGFR and GAK
      • Gene therapy for Dravet Syndrome
      • In silico PROTACs design
  • The team
  • About
  • My research in 2 minutes
    • Artem Babaian: ultra-deep search for novel coronaviruses
    • Danton Ivanochko: a chemical probe for PRDM9
    • Mandeep Mann: a chemical probe for USP5
    • Natasha Anita: depressive biomarkers in diabetes
    • Rachel Harding: 3D structure of Huntingtin
    • Setayesh Yazdani: the druggable human genome
Search

HDACs

The process of HDAC11 Assay Development: linearity and Km calculation

Posted on4th June 20181st July 2019AuthorMegha AbbeyLeave a comment

With previously optimized conditions, the linearity range for HDAC11 was obtained and the Km for the substrate was calculated. The data is posted on Zenodo.

CategoriesHDACs, Megha Abbey, SGC Univ. of Toronto

The process of HDAC11 Assay Development: enzyme stability

Posted on30th April 20181st July 2019AuthorMegha AbbeyLeave a comment

Before performing the kinetic study for calculating the Km for HDAC11, it is important to know the duration of the stability of the protein under the assay conditions. This is being analyzed here.

CategoriesHDACs, Megha Abbey, SGC Univ. of Toronto

The process of HDAC11 Assay Development: buffer screening

Posted on30th April 20181st July 2019AuthorMegha AbbeyLeave a comment

A buffer screen at various pH was performed to pick the buffer that gives the best activity for HDAC11. The dataset is posted on Zenodo.

CategoriesHDACs, Megha Abbey, SGC Univ. of Toronto

The process of HDAC11 Assay Development: effect of additives-preliminary test

Posted on27th April 20181st July 2019AuthorMegha AbbeyLeave a comment

Since the activity of HDAC11 has been observed to be quite low as per the previous data, a preliminary test was performed to check any drastic increase in the activity in the presence of an additive. The data can be found on Zenodo.

CategoriesHDACs, Megha Abbey, SGC Univ. of Toronto

The process of HDAC11 Assay Development: time-course study follow-up (developer)

Posted on27th April 20181st July 2019AuthorMegha AbbeyLeave a comment

The time of incubation and conc. of the developer to be used are important parameters during HDAC11 assay optimization and thus, have been considered here. The dataset is posted on Zenodo.

CategoriesHDACs, Megha Abbey, SGC Univ. of Toronto

The process of HDAC11 Assay Development: follow-up for time-course study

Posted on20th March 20181st July 2019AuthorMegha AbbeyLeave a comment

A follow-up to check the increased fluorescence signals at 0 min of the HDAC11 reaction with its substrate was performed. The data is uploaded on Zenodo.

CategoriesHDACs, Megha Abbey, SGC Univ. of Toronto

The process of HDAC11 Assay Development: time-course study

Posted on9th March 20181st July 2019AuthorMegha AbbeyLeave a comment

Using Boc-Lys-(TFA)-AMC substrate, a preliminary time-course study was initiated to determine the appropriate HDAC11 concentration and the time to be used for the reaction (which are essential parameters to perform Km calculations later). Experimental details are on Zenodo.

CategoriesHDACs, Megha Abbey, SGC Univ. of Toronto

The process of HDAC11 Assay Development: kit-free method

Posted on2nd March 20181st July 2019AuthorMegha AbbeyLeave a comment

In order to develop an assay for HDAC11, a kit-free method is being attempted wherein Boc-Lys-(TFA)-AMC, a previously reported substrate was used to check the activity of HDAC11 in a preliminary experiment. Dataset on Zenodo.

CategoriesHDACs, Megha Abbey, SGC Univ. of Toronto

The process of HDAC11 Assay Development: using kit

Posted on21st February 20181st July 2019AuthorMegha AbbeyLeave a comment

Preliminary tests to check if the Fluor-de-Lys-green HDAC activity kit could be used for developing a high-throughput HDAC11 assay have been performed here using controls and recombinantly purified HDAC11. Details on Zenodo.

CategoriesHDACs, Megha Abbey, SGC Univ. of Toronto

HDAC11 protein purification

Posted on15th January 20181st July 2019AuthorMegha AbbeyLeave a comment

HDAC 11 protein was purified from Sf9 cells using Ni-NTA chromatography. The protein was concentrated to 1.4 mg/ml (above which it tends to precipitate) and flash frozen. The details on the experimental procedures can be found on Zenodo.  

CategoriesHDACs, Megha Abbey, SGC Univ. of Toronto

Post navigation

← Older posts
Newer posts →

Recent Posts

  • Co-expression and purification of recombinant hOvastacin and hFetuin B in insect cell sf9
  • One year of ABHD2 – Where are we now?
  • Efficient Synthesis of Acyclic and Cyclic Pyrazoles for Evaluation as Antiviral nsp2 Protease Inhibitors
  • AViDD Filters: Compound Filtering SOP for Hit to Lead
  • PLCζ1: a promising target for non-hormonal contraceptives

Recent Comments

  • Lakshi Selvaratnam on A systematic review of drug-like ligands bound to helicases in the PDB
  • Tim Willson on A systematic review of drug-like ligands bound to helicases in the PDB
  • Holli-Joi Martin on Multiple Sequence Alignment and Phylogenetic Tree of Human and Viral Helicases
  • Erica Rebouças on Release of brachyury (TBXT) SPR Raw Data
  • Lakshi Selvaratnam on Multiple Sequence Alignment and Phylogenetic Tree of Human and Viral Helicases

Archives

  • October 2023
  • September 2023
  • August 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • September 2022
  • August 2022
  • June 2022
  • March 2022
  • February 2022
  • September 2021
  • August 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017

Categories

  • ACVR1/ALK2
  • Alfredo Picado
  • Alma Seitova
  • ALS-Reproducible Antibody Platform (ALS-RAP)
  • Alzheimer’s disease
  • Amy Ramsey
  • Amy Ramsey (Univ. of Toronto)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Angela Kwak
  • Anirban Ghoshal
  • Antoine Claessens
  • Antoine Claessens
  • Anwar Hossain
  • Ashley Hutchinson
  • Ben Eduful
  • Brain Tumours
  • Carmen Jimenez Antunez
  • Carolyn Marks
  • Catalyst UNC Chapel Hill
  • Cell assay reports
  • Cheryl Arrowsmith (Univ. of Toronto)
  • Chordoma
  • Chromatin factors
  • Claudia Alvarez
  • COVID-19
  • Danton Ivanochko
  • David Dilworth
  • David Drewry
  • Diamond Light Source
  • Diffuse intrinsic pontine glioma
  • Dravet syndrome
  • E3 ligases
  • EGFR and GAK
  • Elizabeth Zoeller
  • Ellie Williams
  • Emory university
  • Ependymoma
  • Epigenetic targets in Medulloblastoma
  • Eve Carter
  • Evianne Rovers
  • EZHIP
  • Fang-Chi Chang
  • Fibrodysplasia ossificans progressiva
  • Gene therapy for Dravet Syndrome
  • Genna Luciani
  • Grant Mills
  • GRIN disorder
  • GTPase-GEF complex
  • Hadley Sheppard
  • HAO1
  • Haresh Ajani
  • HDACs
  • Helicases
  • Huntingtin
  • Huntington’s disease
  • In silico PROTACs design
  • iPSC Disease modelling
  • iPSCs
  • Jacob McAuley
  • Jolene Ho
  • Jong Fu Wong
  • Jose Brandao-Neto
  • Joseph Newman
  • Katheron Intson
  • Lakshi Selvaratnam
  • Leukemia
  • Ligandable Genome
  • Liz Brown
  • Louisa Temme
  • Madison Edwards
  • Magdalena Szewczyk
  • Malaria
  • Mandeep Mann
  • Michael Taylor (SickKids Hospital Toronto)
  • Montreal Neurological Institute
  • Nergis Imprachim
  • Nick Goldman (EBI)
  • Nicola De Maio
  • NMDA
  • Non-hormonal Contraception
  • NSD3
  • Oliver Arnolds
  • Open Secretion Rescue
  • Opher Gileadi
  • Parkinson's disease and neurodevelopmental disorders
  • Peter Brown
  • Pietro Roversi
  • Pietro Roversi (Univ. of Leicester)
  • PRC2
  • PRDM methyltransferases
  • Primary Hyperoxaluria
  • PRMTs
  • Protein purification protocols
  • Rachel Harding
  • Rare disease
  • Ray Truant (McMaster Univ.)
  • READDI-AC
  • Roslin Adamson
  • Sabrina Mackinnon
  • SARS-CoV-2 computational genomics
  • SARS-CoV-2 NSP14
  • Sean O'Byrne
  • Serap Beldar
  • Setayesh Yazdani
  • SETDB1
  • SGC Karolinska
  • SGC UNC Chapel Hill
  • SGC Univ. College London
  • SGC Univ. of Frankfurt
  • SGC Univ. of Oxford
  • SGC Univ. of Toronto
  • Spike
  • Stephanie Tang
  • Stephen R. Armstrong
  • Tamara Maiuri
  • Tammy Havener
  • Taraneh Hajian
  • TBXT (brachyury) inhibitors
  • Thomas M. Durcan
  • Tobias Krojer
  • TREAT-AD
  • Understudied Kinases
  • USP5
  • USPs
  • Victoria Vu
  • WDR proteins
  • WDR41
  • Wen Yih Aw
  • XChem
  • Yufeng Pan

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
openlabnotebooks.org is licensed under a CC-BY licence. 2025 SGC RI
Accessibility
Scroll Up
  • Home
  • Laboratories
    • Active
      • Amy Ramsey (Univ. of Toronto)
      • BCCRC, Univ. of British Columbia
      • BioZone (Univ. of Toronto)
      • Catalyst UNC Chapel Hill
      • Cheryl Arrowsmith (Univ. of Toronto)
      • CMD Oxford
      • Diamond Light Source
      • Emory university
      • Michael Taylor (SickKids Hospital Toronto)
      • Montreal Neurological Institute
      • Nick Goldman (EBI)
      • Pietro Roversi (Univ. of Leicester)
      • Qhetem, USP, Brazil
      • Ray Truant (McMaster Univ.)
      • SGC UNC Chapel Hill
      • SGC Univ. of Oxford
      • SGC Univ. of Toronto
    • Past
      • Antoine Claessens
      • SGC Karolinska
  • People
    • Active
      • Alfredo Picado
      • Alma Seitova
      • Amy Ramsey
      • Angela Kwak
      • Anirban Ghoshal
      • Anwar Hossain
      • Arunima
      • Ashley Hutchinson
      • Ben Eduful
      • Benjamin Dai
      • Claudia Alvarez
      • Danton Ivanochko
      • David Dilworth
      • David Drewry
      • Edward Anderson
      • Elisa Gibson
      • Elizabeth Zoeller
      • Ellie Williams
      • Eve Carter
      • Evianne Rovers
      • Fang-Chi Chang
      • Hadley Sheppard
      • Jong Fu Wong
      • Jose Brandao-Neto
      • Joseph Newman
      • Katheron Intson
      • Lakshi Selvaratnam
      • Liz Brown
      • Louisa Temme
      • Madison Edwards
      • Magdalena Szewczyk
      • Mandeep Mann
      • Muthu Ramalingam Bose
      • Nergis Imprachim
      • Nicola De Maio
      • Oliver Arnolds
      • Opher Gileadi
      • Pegah Ghiabi
      • Peter Brown
      • Peter Stogios
      • Pietro Roversi
      • Rachel Harding
      • Sabrina Mackinnon
      • Sara Boosaliki
      • Serap Beldar
      • Setayesh Yazdani
      • Stephen R. Armstrong
      • Suzanne Ackloo
      • Tamara Maiuri
      • Tammy Havener
      • Taraneh Hajian
      • Thiago dos Santos
      • Thomas M. Durcan
      • Tobias Krojer
      • Victoria Vu
      • Yuanye Yan
      • Yufeng Pan
    • Past
      • Antoine Claessens
      • Carla Alamillo
      • Carmen Jimenez Antunez
      • Carolyn Marks
      • Genna Luciani
      • Grant Mills
      • Haresh Ajani
      • Jacob McAuley
      • Jolene Ho
      • Kaleb Naegeli
      • Megha Abbey
      • Nirav Kapadia
      • Roslin Adamson
      • Sean O’Byrne
      • Wen Yih Aw
  • Diseases
    • Active
      • Alzheimer’s disease
      • Amyotrophic Lateral Sclerosis (ALS)
      • Batten disease
      • Chordoma
      • COVID-19
      • Diffuse intrinsic pontine glioma
      • Ependymoma
      • Fibrodysplasia ossificans progressiva
      • GRIN disorder
      • Huntington’s disease
      • Influenza
      • iPSC Disease modelling
      • Leukemia
      • Malaria
      • Parkinson’s disease and neurodevelopmental disorders
      • Primary Hyperoxaluria
      • Rare disease
    • Past
      • Dravet syndrome
  • Projects
    • Active
      • ACVR1/ALK2
      • ALS-Reproducible Antibody Platform (ALS-RAP)
      • Cell assay reports
      • Chromatin factors
      • E3 ligases
      • Epigenetic targets in Medulloblastoma
      • EZHIP
      • GTPase-GEF complex
      • HAO1
      • HDACs
      • Helicases
      • HERO Glove
      • Huntingtin
      • Influenza computational genomics
      • Investigating Outdoor Mobility of Older Adults
      • iPSCs
      • Ligandable Genome
      • NMDA
      • Non-hormonal Contraception
      • NSD3
      • Open Secretion Rescue
      • PRC2
      • PRDM methyltransferases
      • PRMTs
      • Protein purification protocols
      • READDI-AC
      • SARS-CoV-2 computational genomics
      • SARS-CoV-2 NSP14
      • SETDB1
      • Spike
      • TBXT (brachyury) inhibitors
      • Toronto Open Access SARS-CoV-2 Protein Manufacturing Center
      • TREAT-AD
      • Understudied Kinases
      • USP5
      • USPs
      • WDR proteins
      • WDR41
      • XChem
    • Past
      • EGFR and GAK
      • Gene therapy for Dravet Syndrome
      • In silico PROTACs design
  • The team
  • About
  • My research in 2 minutes
    • Artem Babaian: ultra-deep search for novel coronaviruses
    • Danton Ivanochko: a chemical probe for PRDM9
    • Mandeep Mann: a chemical probe for USP5
    • Natasha Anita: depressive biomarkers in diabetes
    • Rachel Harding: 3D structure of Huntingtin
    • Setayesh Yazdani: the druggable human genome
This site uses cookies: Find out more.